ReShape Lifesciences Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 49

Employees

  • Latest Deal Type
  • M&A

ReShape Lifesciences General Information

Description

Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.

Contact Information

Website
medtimo.com
Formerly Known As
EnteroMedics, Obalon Therapeutics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 7625 Golden Triangle Drive
  • Suite G
  • Eden Prairie, MN 55344
  • United States
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Services
Other Healthcare Technology Systems
Acquirer
Vertical(s)
Corporate Office
  • 7625 Golden Triangle Drive
  • Suite G
  • Eden Prairie, MN 55344
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ReShape Lifesciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Merger/Acquisition 15-Aug-2025 Completed Generating Revenue
14. 2PO 09-Jun-2025 Completed Generating Revenue
13. 2PO 18-Feb-2025 Completed Generating Revenue
12. 2PO 03-Oct-2023 Completed Generating Revenue
11. 2PO 08-Feb-2023 Completed Generating Revenue
10. PIPE 23-Sep-2019 Completed Generating Revenue
9. PIPE 18-Jun-2019 Completed Generating Revenue
8. PIPE 01-Apr-2018 Completed Generating Revenue
7. PIPE 05-Nov-2015 $18.8M $138M Completed Generating Revenue
6. Secondary Transaction - Open Market 11-Feb-2011 $19.1M $119M Completed Generating Revenue
To view ReShape Lifesciences’s complete valuation and funding history, request access »

ReShape Lifesciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. Th
Therapeutic Devices
Eden Prairie, MN
49 As of 2025

Yokneam Ilit, Israel
 

Minneapolis, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ReShape Lifesciences Competitors (10)

One of ReShape Lifesciences’s 10 competitors is Lifeward, a Formerly VC-backed company based in Yokneam Ilit, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lifeward Formerly VC-backed Yokneam Ilit, Israel
Medtronic Corporation Minneapolis, MN
LivaNova Formerly VC-backed London, United Kingdom
Cyberdyne Formerly VC-backed Tsukuba, Japan
Hocoma Corporate Backed or Acquired Volketswil, Switzerland
You’re viewing 5 of 10 competitors. Get the full list »

ReShape Lifesciences Patents

ReShape Lifesciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026112485-A1 Artificial intelligence and machine learning for neuromodulation of neuronal targets in treatment of a medical condition Pending 21-Nov-2024
WO-2026112467-A1 Bio-electronic device to modulate nerve, tumor or organ tissue in cancer pathology and compliment chemotherapy or immunotherapy drugs to targeted cancer pathology Pending 21-Nov-2024

ReShape Lifesciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ReShape Lifesciences Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aberdare Ventures Venture Capital Minority
Ascent Partners (United States) PE/Buyout Minority
Bay City Capital Venture Capital Minority
Charter Life Sciences Venture Capital Minority
InterWest Partners Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

ReShape Lifesciences Acquisitions (5)

ReShape Lifesciences’s most recent deal was a Reverse Merger with Vyome Holdings. The deal was made on 14-Aug-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Vyome Holdings 14-Aug-2025 Reverse Merger Drug Discovery
Obalon Therapeutics 15-Jun-2021 Merger/Acquisition Therapeutic Devices
Apollo Endosurgery (Surgical product line) 17-Dec-2018 Merger/Acquisition Surgical Devices
ReShape Medical 02-Oct-2017 Merger/Acquisition Therapeutic Devices
BarioSurg 22-May-2017 Merger/Acquisition Therapeutic Devices
To view ReShape Lifesciences’s complete acquisitions history, request access »

ReShape Lifesciences ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view ReShape Lifesciences’s complete esg history, request access »

ReShape Lifesciences Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Obalon Therapeutics Carlsbad, CA 2008

ReShape Lifesciences FAQs

  • When was ReShape Lifesciences founded?

    ReShape Lifesciences was founded in 2002.

  • Where is ReShape Lifesciences headquartered?

    ReShape Lifesciences is headquartered in Eden Prairie, MN.

  • What is the size of ReShape Lifesciences?

    ReShape Lifesciences has 49 total employees.

  • What industry is ReShape Lifesciences in?

    ReShape Lifesciences’s primary industry is Therapeutic Devices.

  • Is ReShape Lifesciences a private or public company?

    ReShape Lifesciences is a Private company.

  • What is ReShape Lifesciences’s current revenue?

    The current revenue for ReShape Lifesciences is .

  • How much funding has ReShape Lifesciences raised over time?

    ReShape Lifesciences has raised $174M.

  • Who are ReShape Lifesciences’s investors?

    Aberdare Ventures, Ascent Partners (United States), Bay City Capital, Charter Life Sciences, and InterWest Partners are 5 of 10 investors who have invested in ReShape Lifesciences.

  • Who are ReShape Lifesciences’s competitors?

    Lifeward, Medtronic, LivaNova, Cyberdyne, and Hocoma are some of the 10 competitors of ReShape Lifesciences.

  • When was ReShape Lifesciences acquired?

    ReShape Lifesciences was acquired on 15-Aug-2025.

  • Who acquired ReShape Lifesciences?

    ReShape Lifesciences was acquired by Vyome Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process